Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-060515
Filing Date
2024-05-13
Accepted
2024-05-13 16:05:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2413452d3_424b3.htm 424B3 254940
2 GRAPHIC tm2413452d3_424b3img001.jpg GRAPHIC 11150
  Complete submission text file 0001104659-24-060515.txt   271616
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279157 | Film No.: 24938988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)